share_log

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $5.5

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $5.5

HC Wainwright & Co.維持對Leap Therapeutics的買入,將目標股價下調至5.5美元
Benzinga ·  05/14 19:49

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $7 to $5.5.

HC Wainwright & Co. 分析師Swayampakula Ramakanth維持Leap Therapeutics(納斯達克股票代碼:LPTX)的買入並將目標股價從7美元下調至5.5美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論